Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000633171 | SCV000754386 | likely benign | Congenital amegakaryocytic thrombocytopenia; Essential thrombocythemia | 2024-11-20 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821791 | SCV002069469 | likely benign | not specified | 2021-07-19 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004711246 | SCV005256146 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001272213 | SCV001453977 | likely benign | Congenital amegakaryocytic thrombocytopenia | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004533311 | SCV004725456 | likely benign | MPL-related disorder | 2019-06-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |